Lenz Therapeutics, Inc.
Records under this name other than patents Lenz Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Lenz Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,089,562 | Compositions and Methods for the Treatment of Presbyopia Formerly held In force · High confidence | In force | High confidence | |
| US 9,314,427 | Compositions and Methods for the Improvement of Distance Vision and the Treatment of Refractive Errors of the Eye Formerly held In force · High confidence | In force | High confidence | |
| US 9,320,709 | Storage Stable Compositions and Methods for the Treatment of Refractive Errors of the Eye Formerly held In force · High confidence | In force | High confidence | |
| US 9,833,441 | Compositions and Methods for the Treatment of Presbyopia Formerly held In force · High confidence | In force | High confidence | |
| US 9,844,537 | Compositions and Methods for the Treatment of Presbyopia Formerly held In force · High confidence | In force | High confidence | |
| US 9,968,594 | Compositions and Methods for the Treatment of Presbyopia Formerly held In force · High confidence | In force | High confidence | |
| US 10,052,313 | Compositions and Methods for the Treatment of Presbyopia Formerly held In force · High confidence | In force | High confidence | |
| US 10,064,818 | Compositions and Methods for the Treatment of Presbyopia Formerly held In force · High confidence | In force | High confidence | |
| US 10,307,408 | Contact Lens Compositions and Methods for the Treatment of Presbyopia Formerly held In force · High confidence | In force | High confidence | |
| US 10,617,763 | Compositions and Methods for the Treatment of Presbyopia Formerly held In force · High confidence | In force | High confidence |